Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine. Cephalalgia : an international journal of headache Martinez, J. M., Hindiyeh, N. n., Anglin, G. n., Kalidas, K. n., Hodsdon, M. E., Kielbasa, W. n., Moser, B. A., Pearlman, E. M., Garces, S. n. 2020: 333102420920642

View details for DOI 10.1177/0333102420920642

View details for PubMedID 32340471